Is this product certified?

Yes, the product is manufactured under ISO certification standards.

What is the physical appearance?

The product appears as a white powder with a molecular formula of C12H14N2O7.

How is the product packaged?

The product is packed in drums for safe shipping and storage.

74131-06-9 (E) -5- (2-Carboxyvinyl) -2'-Deoxyuridine

Name: 74131-06-9 (E) -5- (2-Carboxyvinyl) -2'-Deoxyuridine
Brand: Puyer Biopharma Ltd.
SKU: 2230875025

Jiangsu, ChinaPuyer Biopharma Ltd.

US$1.00-30.00

100 kg

Sample price:US$50.00/piece.Request sample

Product profile

Customization

Available

CAS No.

74131-06-9

Formula

C12h14n2o7

Model NO.

74131-06-9

EINECS

N/a

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Industrial

Colour

White

Transport Package

Drum

Specification

99%

Trademark

Puyer

Origin

China

Production Capacity

100000kg/Month

Key features

High Purity Assay: Ensures 99% purity for reliable chemical synthesis and research applications.

Antiviral Mechanism: Acts as a chain terminator to disrupt viral DNA replication effectively.

Broad Market Reach: Exports to North America, Europe, Asia, Africa, and Oceania via major ports.

Flexible Payment: Accepts LC, T/T, PayPal, Western Union, and other secure payment methods.

Fast Lead Time: Off-season delivery within 15 workdays; peak season within one month.

Quality Certified: Manufactured under ISO certification standards for consistent quality.

Stable Shelf Life: Guaranteed 2-year shelf life when stored in cool and dry conditions.

Versatile Application: Used in organic synthesis, analytical chemistry, and antiviral drug development.

Company profile

Puyer Biopharma Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading Company, OtherExport Year: 2016-08-01Nearest Port: shanghai, qingdao, tianjinAverage Response Time: ≤10.24hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryPuyer Biopharma Ltd. is identified as a China-based limited company operating from Nantong, Jiangsu, with manufacturer/factory and trading-company classifications. Its stated scope covers APIs, intermediates, fine chemicals, nutraceuticals, crop science, animal health, and related services. Evidence indicates ISO 9001 certification, 21–30 years of combined R&D engineer experience, 6–10 quality-control staff, 10 production lines, batch production of more than 300 products, and multiple production or testing locations. The supplier exports independently, began exporting in 2016, and reports broad international market coverage. However, the provided information does not establish after-sales service processes, financial credibility, customization execution, or named customer cases. Indexes 8 and 9 identify a different entity, Tieling Municipal People’s Government, and are excluded from supplier conclusions.

Supplier typeThe supplier is described as a factory, manufacturer, and trading company. Puyer Biopharma Ltd. is a China-based limited company located in Nantong, Jiangsu, and its stated business covers production, R&D, and sales of pharmaceutical, chemical, nutrition, agricultural, and related products.

CertificationsThe supplier explicitly reports ISO 9001 certification for its management system. This provides direct evidence of a recognized quality-management certification, although no additional certifications are stated.

R&D capabilityPuyer is described as a high-tech enterprise founded by doctors and specializing in R&D, with 21–30 years of R&D engineer experience. It reports laboratories, testing centers, production bases, and investment in R&D testing and production equipment, directly supporting substantial innovation and technical-development capability.

Production capacityThe supplier reports 10 production lines, batch production of more than 300 products, multiple production bases, and stated annual capacities for salicylic acid, potassium humate, amino acid powder, dicalcium phosphate, and choline chloride. These figures provide explicit evidence of broad and sizable production capability.